Characterization of Relative Bioavailability of a Newly Developed Esflurbiprofen Topical System (EFTS) in Comparison with a Marketed Oral Flurbiprofen-containing Tablet Formulation After Multiple-dose Administration Including EFTS Adhesion Assessment - a Phase I, Open-label, Randomized, 2-period, Cross-over Study in Healthy Subjects
Latest Information Update: 14 Mar 2025
At a glance
- Drugs Esflurbiprofen (Primary) ; Flurbiprofen (Primary)
- Indications Acute pain
- Focus Pharmacokinetics
- Sponsors Teikoku Seiyaku
Most Recent Events
- 06 Mar 2025 Status changed from active, no longer recruiting to completed.
- 21 Feb 2025 New trial record